| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/16/2002 | WO2001098291A3 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 05/16/2002 | WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE |
| 05/16/2002 | WO2001085144A3 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione |
| 05/16/2002 | WO2001083547A3 Anti-inflammatory compounds and uses thereof |
| 05/16/2002 | WO2001081622A8 Diagnosis of diseases associated with dna repair |
| 05/16/2002 | WO2001079155A3 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 05/16/2002 | WO2001074341A3 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant |
| 05/16/2002 | WO2001070662A3 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068143A3 Immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs |
| 05/16/2002 | US20020058706 Method for treating asthma using pregabalin |
| 05/16/2002 | US20020058700 Ion channel modulating agents |
| 05/16/2002 | US20020058692 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058681 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 05/16/2002 | US20020058662 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058066 Outer layer portion containing cilostazol, a water-insoluble substance, such as ethyl cellulose, and a hydrophilic hydrogel forming substance, such as hydroxypropyl methyl cellulose. |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | CA2429012A1 New pharmaceutical compositions based on tiotropium salts and salts of salmeterol |
| 05/16/2002 | CA2428318A1 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 05/16/2002 | CA2428179A1 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204419A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 05/15/2002 | EP1204409A1 Microparticles for pulmonary administration |
| 05/15/2002 | EP1167360A9 Human chymase inhibitors |
| 05/15/2002 | EP1161247A4 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0805813B1 Tricyclic vasopressin antagonists |
| 05/15/2002 | EP0778833B1 Endothelin receptor antagonists |
| 05/15/2002 | EP0733621B1 Novel imidazole derivative and process for producing the same |
| 05/15/2002 | EP0706513B1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 05/15/2002 | CN1349542A Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1349410A Use of heparin-binding antagonists in the inhibition of bradykinin release |
| 05/15/2002 | CN1349407A Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumponiae infections |
| 05/15/2002 | CN1348815A Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use |
| 05/15/2002 | CN1348812A Cough relieving medicated wine |
| 05/15/2002 | CN1348808A Medicine for treating chronic pharyngitis |
| 05/15/2002 | CN1348795A Chinese medicine mixture for treating infantile infection of upper respiratory tract and pulmonitis |
| 05/15/2002 | CN1348788A Medicine for treating chronic pharyngitis and its prepn |
| 05/15/2002 | CN1348784A Kangzhi as one orally taken and externally applied medicine |
| 05/15/2002 | CN1348781A Pulmonotis treating Chinese medicine powder |
| 05/15/2002 | CN1348774A Laryngopharyngitis treating medicine |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/15/2002 | CN1084620C Medicine for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 05/15/2002 | CN1084618C Use of serotonin antagonists (5HT3) for treatment disease |
| 05/14/2002 | US6388095 Indole-containing quaternary ammonium compounds |
| 05/14/2002 | US6387932 Somatostatin agonists |
| 05/14/2002 | US6387918 A tricyclic compound (with oxy and nitrogen atoms in the ring); perticularly useful for treating or preventing psoriasis and other skin diseases |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387900 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387886 Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic |
| 05/14/2002 | CA2263905C Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| 05/14/2002 | CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
| 05/14/2002 | CA2247105C Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic di seases |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/10/2002 | WO2002036816A2 Method of determining susceptibility to diseases |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036593A1 Indole derivatives as pde5-inhibitors |
| 05/10/2002 | WO2002036590A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 05/10/2002 | WO2002036589A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 05/10/2002 | WO2002036571A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 05/10/2002 | WO2002036553A2 Substituted alkanoic acids |
| 05/10/2002 | WO2002036171A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors |
| 05/10/2002 | WO2002036163A2 Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses |
| 05/10/2002 | WO2002036158A1 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses |
| 05/10/2002 | WO2002036114A1 Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 |
| 05/10/2002 | WO2002036113A1 Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) |
| 05/10/2002 | WO2002036106A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 05/10/2002 | WO2002036104A2 Inhalative solution formulation containing a tiotropium salt |
| 05/10/2002 | WO2002036072A2 Method for short-term and long-term drug dosimetry |
| 05/10/2002 | WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 05/10/2002 | WO2001097813A3 Highly concentrated stable meloxicam solutions |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |